NCT06788119Recruiting
Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders
Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders: a Randomized Controlled Trial Using a Mixed Methods Approach
Source: ClinicalTrials.gov · Last updated 16 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this study is to develop and test the efficacy of first-of-its-kind, fully instrumented sensor-based smartphone-guided in-vivo exposure therapy using a just-in-time intervention for anxiety disorder. The main hypotheses are: 1. Both treatment conditions (CBT treatment with IVE and CBT treatment with IVE+SYMPTOMS-JIT) will show efficacy and no statistically significant differences will be found between them. The efficacy will be determined for the differences in pre-post treatment in the used outcome measures. 2. The therapeutic gains obtained in both treatment conditions (IVE and (IVE+SYMPTOMS-JIT) will be maintained at 1-, 6-, and 12-month follow-up periods. 3. Both treatment conditions will be efficient, that is, they will be well-valued by patients and therapists. However, IVE+SYMPTOMS-JIT will be preferred and perceived as less aversive than IVE. 4. The main barriers for the use of this technology are not technological, but rather attitudinal and they can be identified through qualitative studies.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 158 (estimated)
- First submitted
- 19 Dec 2024
- Start date
- 30 Apr 2025
- Primary completion date
- 30 Jun 2027
- Lead sponsor
- Universitat Jaume I
- NCT number
- NCT06788119
What you commit to
- Study type: Interventional
- Planned participants: 158
- From 30 Apr 2025 to the primary completion date, 30 Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Taking anxiolytics during the study (or in the case of taking them, changing drug or dose during the study).
Other illness
- Having current alcohol or drug dependence or abuse, psychosis or severe organic illness.
Other
- Having another psychological problem that requires immediate attention.
- Currently being treated in a similar treatment program.
Who the study is looking for
- Being at least 18 years or older.
- Meeting DSM-5 diagnostic criteria (APA, 2013) for anxiety disorder, specifically specific phobia, agoraphobia, panic disorder and social phobia.
- Being willing to follow the study conditions.
- Sign the consent form.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Jaume I Coordinator of this site? Confirm its status | Castellon | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.